Jpmorgan Chase & Co »

Viking Therapeutics Inc call shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Viking Therapeutics Inc call shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Viking Therapeutics Inc call

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics Inc call held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics Inc call by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.5M 180k 53.01
2024-03-31 $7.7M 94k 82.00
2023-09-30 $664k 60k 11.07
2023-06-30 $2.3M 143k 16.21
2022-12-31 $188k 20k 9.40
2019-03-31 $73k 7.3k 10.00